NORTH HOLLYWOOD, Calif. & SAN DIEGO--(BUSINESS WIRE)--The International Myeloma Foundation (IMF) – the oldest and largest foundation dedicated to improving the life and care of myeloma patients – said data to be presented at this year’s ASH hematology-oncology conference are expected to indicate important new progress in treating myeloma. Data continue to demonstrate benefits for these patients, with improved overall survival results and good quality of life, along with new ways to use existing drugs, including long-term treatment, and new methods of delivery.
